We are live on ! Find out more
EUDA icon

EUDA Health Holdings

35 hedge funds and large institutions have $78M invested in EUDA Health Holdings in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

2% more capital invested

Capital invested by funds: $76.5M → $78M (+$1.57M)

0.03% more ownership

Funds ownership: 4.01%4.04% (+0.03%)

3% less funds holding

Funds holding: 3635 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.6%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change

EUDA Hedge Fund Activity: Q3 2022 in Review

35 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings (EUDA) for Q3 2022, worth a combined $78M — up 2% from $76.5M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of EUDA and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.

The largest buyer was Glazer Capital LLC, adding an estimated $1.65M. The largest seller was Logan Stone Capital, exiting entirely with an estimated $1.24M sold.

  • 35 institutional investors held EUDA Health Holdings (EUDA) as of Q3 2022, down from 36 in Q2 2022.
  • Funds reported $78M of EUDA Health Holdings stock for Q3 2022, up 2% quarter-over-quarter.
  • 3 funds opened new EUDA Health Holdings positions in Q3 2022 and 4 closed out, a net change of -1 holder.
  • The largest EUDA Health Holdings buyer in Q3 2022 was Glazer Capital LLC, an estimated $1.65M added.
  • The largest EUDA Health Holdings seller in Q3 2022 was Logan Stone Capital, an estimated $1.24M sold.

Based on aggregated 13F filings for Q3 2022.